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Diabetes mellitus has become a global epidemic as its prevalence is steadily increasing everywhere at an alarming rate, 
most markedly in the India. Traditional Indian system of medicine based on herbal therapies is being practiced since ancient 
times and has been proved very effective against number of diseases. Trigonella foenum-graecum (Tfg) and Cinnamomum 
zeylanicum (Cz), the two spices, possess multiple medicinal properties. Hence present study is aimed to evaluate the 
protective effects of these plants on the oxidative DNA damage in diabetic rats. The presence of DNA base oxidation was 
investigated by modified comet assay which uses bacterial repair enzymes, formamidopyrimidine glycosylase and 
Endonuclease III which can measure oxidatively damaged purines and pyrimidines, respectively. Diabetes induced 
alteration in total antioxidant capacity (TAC), generation of superoxide anion and the levels of GSH, GSSG, NADH, NAD+, 
NADPH and NADP+ were monitored. Diabetes was induced by intravenous injection of alloxan, followed by oral 
administration of aqueous suspension of Tfg seeds and bark of Cz. Treatment of Tfg and Cz significantly restored the altered 
level of superoxide anion, TAC, ratios of GSH/GSSG, NAD(P)H/NAD(P)+ and NADH/NAD+ in the diabetic group. 
Furthermore, both the treatment effectively decreased the level of oxidatively damaged purine and pyrimidine bases.  
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Diabetes mellitus (DM) is a chronic metabolic 
disorder characterized by hyperglycemia resulting 
from either lack of insulin production or resistance to 
insulin. Both genetic and environmental factors 
contribute in the development and progression of 
diabetes. The pervasiveness of DM has risen to 
epidemic proportions worldwide. In diabetic 
condition, oxidative stress induced by the presence of 
excessive reactive oxygen species (ROS) and reactive 
nitrogen species (RNS) is closely associated with 
chronic inflammation, leading to potential tissue 
damage. All the important biomolecules including 
proteins, lipids and DNA are susceptible to oxidative 
damage. Diabetes mellitus induced oxidative stress, 
has also been reported to damage DNA
1
. Oxidative 
DNA damages include oxidiation of purines and 
pyrimidines bases, single-strand (SSBs) and  
double-strand (DSB) breaks as well as DNA-DNA 
and DNA-protein cross links
2
. ROS may also  
damage DNA indirectly, through reaction with lipids, 
proteins, and other cellular components to produce 
electrophilic species that can react with DNA
3
. Both, 
in type 1 diabetes mellitus (T1DM) and type 2 
diabetes mellitus (T2DM), induction of oxidative 
stress due to hyperglycemia have been reported as 
major cause of complications
1
. It has also been 
demonstrated that hyperglycemia is associated  
with an increased production of free radicals in  
the mitochondria and may contribute to a greater 
DNA damage
2,3
.  
The management of diabetes involves both the non 
pharmacological and pharmacological approaches. 
Due to the high cost and serious side effects of 
hypoglycemic drugs, the focus has been shifted  
to herbal medicines which are not only easily 
available but also having no toxic effects on  
other body functions. More than 10000 plants  
have been described to be experimentally or 
ethnopharmacologically used in the treatment of 
diabetes
4
 and various plants extracts with medicinal 
values have been screened by many scientists in the 
field of diabetic research
4
. Most of the plants contain 
glycosides, alkaloids, terpenoids, flavanoids, 
carotenoids etc. that are frequently implicated as 
having antidiabetic effects. Several plants, such as 
Azardirachta indica, Eugenia jambolana, Momordica 
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charantia, Ocimum sanctum, Gymnema sylvestre and 
Trigonella foenum-graecum L. etc are being used 
commonly in the treatment of diabetes. In the present 
study, two such medicinal plants that are widely used 
to manage diabetes, Trigonella foenum-graecum (Tfg) 
and Cinnamomum zeylanicum (Cz), commonly known 
as fenugreek and cinnamon, respectively, are selected 
to study their effects on oxidative stress and DNA 
damage in experimental diabetic rats. Studies on 
different animal models  proved that fenugreek has 
strong antidiabetic properties
5
. Several studies have 
demonstrated that fenugreek seed extract, mucilage of 
seeds, and leaves can decrease blood glucose levels in 
human and experimental animals
5,6,9
. Cinnamon, a 
natural product with long history of safety, is rich in 
polyphenolic compounds that have been shown to 
improve the antioxidant status. Cinnamon belongs to 
the family Lauraceae, and its main components are 
cinnamaldehyde, cinnamic acid, tannin and 
methylhydroxychalcone polymer (MHCP). Cinnamon 
bark possesses significant anti-diabetic, anti-allergic, 
anti-ulcerogenic, antipyretic and antioxidant 
properties
7,8,10
.
 
Both are being used as folk medicine 
not only in diabetes but also in number of other 
diseases
9,10
. The antihyperglycemic and antioxidant 
effect of Tfg seed and Cz bark have already been 
reported
5-10
.  
The present study is undertaken to evaluate the 
status of total antioxidant capacity (TAC), 
nonenzymatic antioxidants reduced and oxidized 
glutathione namely (GSH and GSSG), reduced and 
oxidized pyridine nucleotides (NAD(P)
+
 and 
NAD(P)H), and their ratio NAD(P)H/NAD(P)
+ 
in 
tissues of diabetic rats, which will give estimates of 
redox status of the cell resulting in damage to the vital 
molecule, DNA. Attempts have also been made to 
evaluate the mechanism of DNA damage by measured 
oxidatively damaged purines and pyrimidines bases 
by the modified comet assay. In the modified comet 
assay, two bacterial enzymes, formamidopyrimidine 
glycosylase (Fpg) and endonuclease III (Endo) are 
used in conjunction with comet assay which remove 
oxidatively damaged purine and pyrimidine bases, 
respectively, and create a break in the DNA strand by 
the associated action of endonuclease which are then 
measured by comet assay and compared with lysis 
buffer treated slides. Aqueous suspension of 
powdered Tfg seed and bark of Cz were given as 
treatment to diabetic animals to analyse whether they 
have any protective effects against altered redox 
balance and DNA damage. The standard antidiabetic 
drug, glibenclamide, was taken as positive control. 
 
Materials and Method 
Chemicals  
Chemicals used in the present study were of 
highest purity/analytical grade. Dimethyl sulfoxide, 
alloxan monohydrate, endonuclease III (Endo III) and 
formamidopyrimidine-DNA glycosylase (Fpg), 
oxidized cytochrome C, phorbol 12-myristate-13-
acetate (PMA), reduced and oxidized glutathione, N-
ethylmaleimide (NEM), oxidized and reduced 
pyridine nucleotides NAD(P)
+ 
and NAD(P)H), 
nicotinamide, N-ethyldibenzopyrazine ethyl sulphate 
(PES), 3-(4,5-dimethythiazolyl)- 2,5- diphenyl 
tetrazolium bromide (thiazolyl blue or MTT), alcohol 
dehydrogenase, glucose-6-phosphate dehydrogenase, 
glucose-6-phosphate, ethylenediaminotetraacetic acid 
tetrasodium salt, agarose (normal melting and low 
melting), Hisep, trypan blue, 4-(2-hydroxyethyl)-
pierazine-1-ethanesulphonic acid (HEPES) buffer, 
potassium hydroxide, metmyoglobin, trolox  
and ABTS [2, 2-azinobis-(3-ethylbanzothizoline-6-
sulfonic acid) disodium salt] were purchased from 
Sigma Chemical Co., St. Louis, Mo. Sarcosine, was 
obtained from Merck, Germany.  
 
Experimental animals 
Adult male albino rats of Wistar strain (Rattus 
norvegicus) weighing about 140 ± 10 g were used in 
the present study. Rats were obtained from the animal 
facilities of Defence Research and Development 
Establishment, Gwalior, India, and were maintained 
in a light (light-dark cycle of 12 h each) and 
temperature (25 ± 2C) controlled animal room of 
our department on standard pellet diet (obtained from 
Amrut Rat & Mice Feed, New Delhi, India) and tap 
water ad libitum. Rats were acclimatized for one week 
prior to the start of the experiment. The study was 
approved by the institutional ethical committee on 
animal use of Jiwaji University (Ethical Code 
IAEC/JU/2011/01). 
 
Experimental design 
Rats were randomly divided into five groups of six 
animals each, and were given following treatments: 
Group 1: Control (healthy rats with normal blood 
glucose level); Group 2: Diabetic (i.v. injection of 
alloxan 55 mg/kg body weight); Group 3: Diabetic + 
Tfg seed powder (1740 mg/kg body weight); Group 4: 
Diabetic + Cz bark powder (200 mg/kg body weight); 
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and Group 5: Diabetic + Glibenclamide (0.6 mg/kg 
body weight) 
 
Induction of experimental diabetes and treatment  
Diabetes was induced in the overnight fasted adult 
rats by single intravenous injection of 55 mg/kg body 
weight of alloxan monohydrate dissolved in normal 
saline (0.85% NaCl)
5
. Diabetes was confirmed by 
blood glucose estimation after 48 h by an electronic 
glucometer. The rats with fasting glucose level above 
300 mg/dL were considered diabetics and selected for 
the study.  
Trigonella foenum-graecum (Tfg) seeds and 
Cinnamomum zeylanicum (Cz) bark were purchased 
from the local herbal market, cleaned, dried and finely 
powdered. The plant materials were identified by the 
School of Studies in Botany, Jiwaji University, 
Gwalior. Aqueous suspension of both powdered  
Tfg seeds and Cz bark were prepared and doses  
1740 mg/kg body weight
5,10
 and 200 mg/kg body 
weight, respectively
11,12
, were given orally to the 
diabetic rats with the help of cannula, daily for two 
weeks.
 
For positive control a group of rats was given 
glibenclamide at a dose of 0.6 mg/kg body weight 
orally for two weeks
13
 and a separate group of rats 
received equivalent volume of water for the same 
period of time and served as the control. 
 
Collection of blood, isolation of lymphocytes and tissues  
The blood was collected 24 h after the last 
treatment via ocular bleeding in tubes containing 
EDTA from the animals for lymphocyte separation 
and also in tubes without EDTA for serum separation. 
Blood samples were diluted with equal volume of 
phosphate buffer saline (PBS), layered on the top of a 
Ficoll solution (1.077 g/mL). The interface containing 
the lymphocytes was collected after sedimentation of 
erythrocytes at 1000 g for 10 min at room 
temperature. The collected lymphocytes were washed 
twice with phosphate buffer saline (PBS), pH 7.4, and 
cell viability was checked by trypan blue dye 
exclusion test
14
. The lymphocytes samples with 
viability >95% were used for various estimations. 
After blood collection, rats were humanly killed by 
cervical dislocation; different tissues were excised off, 
washed with 0.9% NaCl and used for different 
estimations. 
 
Estimations 
Superoxide anion release was measured by 
superoxide dismutase inhibitable reduction of 
ferricytochrome c
15
. PMA (polymormphonucleocytes) 
(3 × 10
5
) were incubated in PBS-EDTA buffer  
(pH 7.4) with phorbol-12, 13-dibutyrate (PDBu) in a 
total volume of 1 mL at 37C for 15 min. The final 
concentration of ferricytochrome c and PDBu were  
50 nM/L and 100 nM/L, respectively. The change in 
absorbance was measured spectrophotometrically at 
550 nm for 10 min with a double beam Shimadzu 
UV-160A spectrophotometer (Shimadzu Seisakusho 
Ltd., Kyoto, Japan) at room temperature. The amount of 
superoxide anion released into the medium was 
calculated by using molar extinction coefficient of 
reduced cyochrome c, 2.1X 10
4 
M
−1 
cm
−1 
and the 
concentration is expressed as n mole O2
.−
/ 10
6
 cells/min. 
Total antioxidant capacity (TAC) in serum was 
measured by the method described by Rice-Evans and 
Miller
16
. The reagents were mixed as follows: 8.4 µL 
of sample, 489 µL of buffer (0.1 M PBS, pH 7.4),  
36 µL of 70 µM metmyoglobin, and 300 µL of 5 mM 
ABTS [2, 2-azinobis-(3-ethylbanzothizoline-6-
sulfonic acid) disodium salt], with vortexing. The 
reaction was started by addition of 167 µL of 450 µM 
H2O2 and the absorbance change per min was 
recorded at 734 nm for 6 min. The total antioxidant 
capacity in serum was calculated by calibration curve 
using trolox (2.5 mm) as standard and values were 
expressed as mmol trolox equivalent/L. 
The levels of reduced and oxidized glutathione 
(GSH and GSSG) were estimated by the method 
described by Hssin and Hilf
17
. Approximately 250 mg 
of tissues were homogenised in solution consisted of 
3.75 mL phosphate EDTA buffer (0.1 M sodium 
phosphate buffer containing 5.0 mM EDTA, pH 8.0) 
and 1.0 mL of 25% HPO3, which were used as protein 
precipitant and GSH or GSSG was assayed in 
supernatant obtained after centrifugation at 10000 g 
for 30 min. To 0.5 mL of the 10000 g supernatant,  
4.5 mL of phosphate EDTA buffer, pH 8.0, was added 
for GSH estimation. The final mixture contained  
0.1 mL diluted tissue supernatant, 1.8 mL phosphate 
EDTA buffer and 0.1 mL o-phthaldehyde (1 mg/mL) 
and fluorescence at 412 nm was determined with 
excitation at 350 nm. For estimation of GSSG, to  
0.5 mL of 10000 g supernatant, 0.2 mL of  
N-ethylmaleimide (NEM, 0.04 M) was added and 
incubated at room temperature for 30 min to interact 
with GSH present in the tissue. To this mixture  
4.3 mL of 0.1 N NaOH was added. 0.1 mL of this 
mixture was used for the assay of GSSG in the 
manner identical to GSH except that 0.1 N NaOH was 
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used as diluents in place of phosphate EDTA buffer. 
Both GSH and GSSG standard curves were prepared 
in similar manner using the concentration range of  
10 to 100 µg. The levels in tissues were expressed as 
µg GSH or GSSG g
−1 
tissue.  
Oxidized and reduced pyridine nucleotides (NAD
+
, 
NADP
+
, NADH and NADPH) were assayed by the 
method of Zerez et al.
18
. A 10% homogenate was 
prepared in 1 M Tris-HCl buffer (pH 8.0) and 
centrifuged at 9500 g for 20 min in a refrigerated 
centrifuge. To 0.1 mL of resulting supernatant,  
1.9 mL extraction buffer (containing 100 mM Na2CO3 
and 10 mM nicotinamide) was added and kept at 0˚C 
for 30 min. The frozen mixture was thawed quickly at 
room temperature water bath and divided into two 
equal parts, one part was used for estimation of NAD
+ 
+ NADH or NADP
+ 
+ NADPH and the other part was 
incubated at 60ºC for 30 min, quickly chilled and used 
for the estimation of only reduced form of pyridine 
nucleotides. For assay of total NAD (NAD
+
 + NADH) 
or NADH, the reaction mixture containing 2.0 µM  
N-ethyldibenzopyrazine ethyl sulphate (PES), 0.5 µM 
3-(4,5-dimethythiazolyl)- 2,5- diphenyl tetrazolium 
bromide (thiazolyl blue or MTT), 0.25 U of alcohol 
dehydrogenase, 600 µM ethanol and 0.1 mL extract 
(for NAD
+ 
+ NADH) or 0.1 mL heat treated extract 
(for NADH estimation) in the total volume of 1.0 mL. 
Absorbance change per min was recorded at 570 nm 
for 5 min. For assay of total NADP (NADP
+
 + 
NADPH) or NADPH, the reaction mixture containing 
5.0 µM Na4EDTA, 2.0 µM PES and 0.5 µM MTT, 
1.3 U glucose-6-phosphate dehydrogenase, 1.0 µM 
glucose-6-phosphate and 0.1 mL extract (or 0.1 mL 
heat treated extract) in the total volume of 1.0 mL. 
Absorbance change was recorded at 570 nm for  
5 min. For standard curve, varying concentrations of 
NAD
+
, NADH, NADP
+
 and NADPH ranging from  
1 to 4 pmole in a total volume 0.5 mL were taken. 
The rest of the procedure remained similar to the 
estimation of NAD
+
 or NADP
+
. The results were 
expressed as pmole NAD(P) or NAD(P)H present 
gm
−1 
tissue. 
Modified bases were estimated by Fpg- Endo 
enzyme treatment in combination with the comet 
assay based on Collin’s protocols19 and described 
earlier
20
. A homogenate (25% w/v) of fresh tissue was 
prepared in chilled homogenizing buffer (0.075 M 
NaCl containing 0.024 M EDTA, pH 7.2) in a Potter 
Elvehjem homogenizer with a single stroke. The 
nuclei were obtained by centrifugation at 700 g for  
10 min at 4C and the pellet was gently resuspended 
in 3.0 mL of chilled homogenizing buffer. Seventy 
five μL of normal melting agarose (1% prepared in 
0.1 M sodium phosphate buffer, pH 7.2, containing 
0.9% NaCl) was quickly layered on end-frosted slide, 
covered gently with another slide, and allowed to 
solidify. The upper slide was carefully removed and 
the precoated slide was coated with 100 μL of a 
mixture containing equal volumes of sample (nuclei 
preparation) and low melting agarose (2% in 
phosphate buffer saline). The slides were placed in 
cold lysis buffer (2.5 M NaCl, 0.1 M Na2EDTA, 0.01 
Tris-HCl, 1% Triton X-100, 10% DMSO, pH 10) 
overnight at 4C (minimum of 12 h). For the enzyme 
treatment, four slides were prepared from each cell 
treated sample: ―lysis‖, ―buffer‖, ―Fpg‖ and ―Endo 
III‖. After lysis, slides ―buffer‖, ―Fpg‖ and ―Endo III‖ 
were washed 3 times at 4C, 5 min each time, with 
enzyme buffer (40 mM HEPES, 0.1 M KCl, 0.5 mM 
EDTA, 0.2 mg/mL BSA, adjusted to pH 8 with 
KOH). Then 50 µL of enzyme buffer, Fpg solution or 
Endo III (1 µg/mL of Endo III or Fpg) solution are 
placed onto the gels of the corresponding slides, 
covered with coverslips and incubated at 37C for  
30 min in a moist box. The slide labelled as ―lysis‖ 
remained in the lysis solution during the incubation of 
rest of the slides. At the end of the incubation period, 
the cover slips were removed and all slides, including 
the ―lysis‖ slides, were placed in an electrophoresis 
chamber containing electrophoresis solution (0.3 M 
NaOH, 1 mM EDTA). Electrophoresis was carried 
out for 30 min at constant voltage of 0.8 V/cm 
(measured between the electrodes across the platform 
carrying the slides) and the current around 300 mA. 
After electrophoresis slides were neutralized by 
adding Tris-HCl buffer (0.4 M, pH 7.5) in a drop-wise 
fashion onto the slides. The whole procedure was 
performed in dim light to minimize the artefactual 
DNA damage. Just before visualization, each slide 
was stained with 50 µL of ethidium bromide  
(20 µg/mL), rinsed with water and covered with a 
cover slip. The slides were observed at 10X 
magnification with a Leica Optiphase microscope 
equipped with an excitation filter of 515-560 nm and 
barrier filter of 590 nm. A total of 100 cells were 
scored per tissue per animal (50 from each replicate 
slide). The nuclei were divided into five different 
categories on the basis of percentage of DNA in the 
tail using TriTek CometScore
TM
 Freeware v1.5 
software. The nuclei having 0-10% of tail DNA were 
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categorized under 0 stage, 10-25% tail DNA under 
stage I, 25-50% tail DNA under stage II, 50-75% tail 
DNA under stage III and the nuclei having tail DNA 
>75% were categorized under stage IV (Fig. 1). The 
results are expressed as DNA damage index, 
calculated as #0 + #1 + #2 + #3 + #4/ # of cell scored 
where # is the total number of nuclei counted.  
 
Statistical analyses 
Results are expressed as mean ± S.E. of six sets of 
observations taken on different days. Statistical 
analyses were performed using Sigma Stat Statistical 
software version 2.0. All the statistical analyses were 
performed using one-way analysis of variance post 
hoc Bonferroni’s multiple comparison test applied 
across the treatment groups. Significance was based 
on P value < 0.05. 
 
Results  
Effect of Tfg seeds and Cz bark on superoxide anion release 
and total antioxidant capacity (TAC) in tissues of control and 
diabetic rats 
The alloxan induced diabetes caused significantly 
increased rate of generation of superoxide anion (O2
.−
) 
in the lymphocytes of rats. The increase in the levels 
of superoxide anion was 160% in diabetic group when 
compared with the control. When diabetic rats were 
treated with Tfg, Cz and glibenclamide at a dose of 
1740 mg/kg, 200 mg/kg and 0.6 mg/kg body weight 
for two weeks, superoxide anion levels were 
decreased by 48%, 38% and 53%, respectively, in the 
lymphocytes, when compared with untreated diabetic 
group (Fig. 2). 
The total antioxidant capacity (TAC) was also 
affected by alloxan induced experimental diabetes. 
The decrease in TAC and recovery after treatment 
was not very high as compared to the other 
parameters, but it was statistically significant. The 
decrease in TAC in the serum of diabetic rats was 
42%, when compared with control (Fig. 2). The 
diabetic group receiving treatment of Tfg, Cz and 
glibenclamide orally for two weeks showed a increase 
of 42%, 27% and 60%, respectively, in the serum of 
diabetic rats, when compared with untreated diabetic 
group (Fig. 2).  
 
Effect of Tfg seeds and Cz bark on the levels of GSH, GSSG 
and their ratio GSH/GSSG in tissues of control and diabetic 
rats  
The present study showed that oral administration 
of aqueous suspension of Tfg seeds and Cz bark 
powder significantly increased in the levels of  
GSH and corresponding decrease in the levels of 
GSSG, which leads to increase in GSH/ GSSG ratio, 
when compared with untreated diabetic group. 
Administration of alloxan caused 52% decrease in the 
level of GSH in the liver and 39% decrease in the 
brain while increase in the levels of GSSG were 72% 
in the liver and 48% in the brain of diabetic group 
when compared with control. Decreased levels of 
GSH and increased levels of GSSG caused decrease 
in the ratio of GSH/GSSG in the tissues of diabetic 
rats. The ratio of GSH/GSSG was decreased by 72% 
in the liver and 59% in the brain, respectively, when 
compared with control (Table 1). 
When the diabetic rats were given treatment of Tfg, 
Cz and glibenclamide for two weeks, GSH levels 
were increased by 51%, 21%, 72% in the liver and 
41%, 19%, 54% in the brain, while the levels of 
GSSG were decreased by 28%, 9%, 33% in the liver 
and 21%, 7%, 29% in the brain, respectively, when 
compared with untreated diabetic group (Table 1). 
Similarily, when the Tfg, Cz and glibenclamide 
treated diabetic rats were compared with untreated 
 
 
Fig. 1 — Different stages of DNA damage in isolated nuclei 
 
 
Fig. 2 — Effect of Tfg and Cz on the level of superoxide anion in 
lymphocytes and total antioxidant capacity in serum of control 
and diabetic group. Where, Tfg- Trigonella foenum-graecum,  
Cz- Cinnomomum zeylanicum, Gli- Glibenclamide 
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diabetic group, increase in the ratios of GSH/GSSG 
were 110%, 34%, 159%, in the liver and 88%, 28%, 
118%, respectively, in the brain.  
 
Effect of Tfg seeds and Cz bark on the levels of NADPH, 
NADP+, NADH, NAD+ and their ratio NADPH/NADP+, 
NADH/NAD+ in tissues of control and diabetic rats 
The present study clearly showed that the alloxan 
induced diabetes caused decrease in the levels of 
NADPH and NADH and corresponding increase in 
the levels of oxidized pyridine nucleotide i.e. NADP
+ 
and NAD
+
 indicating the redox imbalance and 
conditions of oxidative stress. There was 23% and 
44% decrease in the level of NADPH and 
corresponding 239% and 189% increase in the levels 
of NADP
+
 in the liver and the brain, respectively,  
in diabetic rats when compared with the control 
(Table 2). Similarly decrease in the levels of NADH 
by 64%, 58% and corresponding increase in the levels 
of NAD
+
 by 454%, 87% were observed, in the liver 
and the brain of diabetic group, respectively, when 
compared with control group (Table 3).  
The increase in the levels of NADPH was 17%, 
10%, and 23% in the liver and 38%, 22%, and 56% in 
the brain on treatment with Tfg, Cz and glibenclamide 
at dose of 1740 mg/kg, 200 mg/kg and 0.6 mg/kg body 
weight, respectively, for two weeks. The decrease 
observed in NADP
+
 levels was 45%, 28%, and 60% in 
the liver and 46%, 37%, and 53% in the brain of rats 
given similar treatment of Tfg, Cz and glibenclamide 
orally for two weeks, respectively, (Table 2). 
When the diabetic rats were given Tfg, Cz and 
glibenclamide treatment for two weeks, 82%, 51% 
and 137% increase in NADH levels while 51%, 31% 
and 67% decrease in the NAD
+
 levels in the hepatic 
tissue likewise 72%, 44% and 118% increase in  
NADH levels while 31%, 19% and 34% deacrease  
in NAD
+
 levels in the brain, respectively, were 
observed when compared with untreated diabetic  
group (Table 3).  
The redox status measured by the ratio of 
NADPH/NADP
+
 and NADH/NAD
+
, an indicator of 
oxidative stress, was found to be significantly reduced 
by 78% and 93% in the liver and 24% and 78% in the 
brain of diabetic rats when compared with control. 
After oral administration of Tfg, Cz and 
glibenclamide, the levels were restored by increase in 
the ratio of both NADPH/NADP
+
 and NADH/NAD
+
 
as 115%, 56%, 210% and 211%, 158%, 605% in the 
liver and 161%, 97%, 242% and 150%, 80%, 237% in 
the brain of diabetic rats, respectively, when 
compared with untreated group (Tables 2 & 3). 
Treatment of Tfg and Cz showed protection against 
diabetes induced disturbances in the redox status in 
the diabetic rats. 
 
Effect of Tfg seeds and Cz bark on the level of DNA damage 
in tissues and the lymphocytes of control and diabetic rats 
The diabetes induced damage to purine and 
pyrimidine bases were monitored by modified comet 
assay. In this assay, two bacterial glycosylases, Fpg 
and Endo III, which remove the damaged purines and 
Table 1 — Effect of oral administration of Trigonella foenum graecum seeds and Cinnamomum zeylanicum bark powder for two 
weeks on GSH, GSSG and their ratio GSH/GSSG in the liver and the brain of control and diabetic rats 
 Groups GSH GSSG GSH/GSSG 
Liver     
 Control 1631.1 ± 9.7 421.4 ± 2.8 3.87 
 Diabetic 785.5 ± 2.1*** 722.8 ± 2.9** 1.08 
 Diabetic + Tfg (1740 mg/kg) 1183.5 ± 2.4*** 521.3 ±3.9*** 2.27 
 Diabetic + Cz (200 mg/kg) 953.5 ± 13.2** 656.7 ± 2.1** 1.45 
 Diabetic + Gli (0.6 mg/kg) 1351.5 ± 2.3*** 481.7 ± 2.2*** 2.80 
Brain     
 Control 425.4 ± 3.5 291.1 ± 23.6 1.46 
 Diabetic 261.6 ± 2.4** 431.8 ± 2.7*** 0.60 
 Diabetic + Tfg (1740 mg/kg) 370.1 ± 3.2** 341.7 ± 2.7** 1.13 
 Diabetic + Cz (200 mg/kg) 310.8 ± 2.9* 400.9 ± 2.4* 0.77 
 Diabetic + Gli (0.6 mg/kg) 402.9 ± 4.2*** 308.3 ± 4.7** 1.31 
GSH and GSSG levels are expressed as µg GSH or GSSG g tissue−1. 
Results are mean ± S.E. of six set of observation. * P < 0.05, ** P < 0.001, *** P < 0.0001 and # P > 0.05 when compared with control. 
Diabetic rats were given aqueous suspension of powdered Trigonella foenum graecum seed and Cinnamomum zeylanicum bark orally at a 
dose of 1740 mg/kg body weight (Tfg) and 200 mg/kg body weight (Cz), with the help of cannula, daily for two week.  
Glibenclamide (Gli) is taken as positive control and 0.6 mg/kg body weight was given. 
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pyrimidines, respectively, and create strand breaks at 
the abasic sites are used. In present study, diabetic 
group showed extensive DNA damage and the 
damage index was increased by 777% in the liver, 
1182% in the brain and 795% in the lymphocytes in 
lysis treated slides in rats, respectively, when 
compared with control while 207%, 199% and 138% 
damage were found in the liver, the brain and the 
lymphocytes of diabetic group, respectively, when 
compared with buffer treated slides of the same 
group. The treatment  of  slides with Fpg and Endo III  
caused significantly high increase in the damage 
index as compared to the lysis treated slides in the 
liver, the brain and the lymphocytes of experimental 
diabetic rats (Table 4). The increase caused by Fpg 
and Endo III was 30% and 28% in the liver, 19% and 
29% in the brain, 34% and 73% in the lymphocytes of 
diabetic group. When comparison was made with the 
Fpg and Endo III treated control group, increased 
damage index was found in the liver, brain and 
lymphocytes and it increase was 184%, 713% and 
434%, respectively, by Fpg treatment and 425%, 
Table 2 — Effect of oral administration of Trigonella foenum graecum seeds and Cinnamomum zeylanicum bark powder for two 
weeks on NADPH, NADP+ and their ratio NADPH/NADP+ in the liver and the brain of control and diabetic rats 
 Groups NADPH NADP+ NADPH/NADP+ 
Liver     
 Control 2.80 ± 0.05 1.60 ± 0.03 1.75 
 Diabetic 2.15 ± 0.04*** 5.43 ± 0.17*** 0.39 
  Diabetic + Tfg (1740 mg/kg) 2.52 ± 0.02** 2.97 ± 0.06** 0.84 
 Diabetic + Cz (200 mg/kg) 2.37 ± 0.02** 3.92 ± 0.11** 0.61 
 Diabetic + Gli (0.6 mg/kg) 2.64 ± 0.02*** 2.18 ± 0.08*** 1.21 
Brain     
 Control 0.81 ± 0.02 0.46 ± 0.01 1.76 
 Diabetic 0.45 ± 0.01** 1.33 ± 0.02*** 0.33 
 Diabetic + Tfg (1740 mg/kg) 0.62 ± 0.01*** 0.72 ± 0.01** 0.86 
 Diabetic + Cz (200 mg/kg) 0.55 ± 0.02** 0.84 ± 0.01** 0.65 
 Diabetic + Gli (0.6 mg/kg) 0.70 ± 0.01*** 0.62 ± 0.02*** 1.13 
NADPH and NADP+ levels are expressed as µg NADPH or NADP+ g tissue−1. 
Results are mean ± S.E. of six set of observation. * P < 0.05, ** P < 0.001, *** P < 0.0001 and # P > 0.05 when compared with control. 
Diabetic rats were given aqueous suspension of powdered Trigonella foenum graecum seed and Cinnamomum zeylanicum bark orally at a 
dose of 1740 mg/kg body weight (Tfg) and 200 mg/kg body weight (Cz), with the help of cannula, daily for two week.  
Glibenclamide (Gli) is taken as positive control and 0.6 mg/kg body weight was given. 
 
Table 3 — Effect of oral administration of Trigonella foenum graecum seeds and Cinnamomum zeylanicum bark powder for two 
weeks on NADH, NAD+ and their ratio NADH/NAD+ in the liver and the brain of control and diabetic rats 
 Groups NADH NAD+ NADH/NAD+ 
Liver     
 Control 6.35 ± 0.13 2.17 ± 0.05 2.92 
 Diabetic 2.28 ± 0.05*** 12.03 ± 0.32*** 0.19 
 Diabetic + Tfg (1740 mg/kg) 4.15 ± 0.20*** 5.85 ± 0.13** 0.59 
 Diabetic + Cz (200 mg/kg) 3.45 ± 0.10** 8.35 ± 0.22* 0.49 
 Diabetic + Gli (0.6 mg/kg) 5.42 ± 0.19*** 4.03 ± 0.09*** 1.34 
Brain     
 Control 2.05 ± 0.06 1.51 ± 0.03 1.35 
 Diabetic 0.86 ± 0.02*** 2.83 ± 0.02** 0.30 
 Diabetic + Tfg (1740 mg/kg) 1.48 ± 0.03** 1.95 ± 0.03** 0.75 
 Diabetic + Cz (200 mg/kg) 1.24 ± 0.02** 2.28 ± 0.06** 0.54 
 Diabetic + Gli (0.6 mg/kg) 1.88 ± 0.02*** 1.86 ± 0.02*** 1.01 
NADH and NAD+ levels are expressed as µg NADPH or NADP+ g tissue−1. 
Results are mean ± S.E. of six set of observation. * P < 0.05, ** P < 0.001, *** P < 0.0001 and # P > 0.05 when compared with control. 
Diabetic rats were given aqueous suspension of powdered Trigonella foenum graecum seed and Cinnamomum zeylanicum bark orally at a 
dose of 1740 mg/kg body weight (Tfg) and 200 mg/kg body weight (Cz), with the help of cannula, daily for two week.  
Glibenclamide (Gli) is taken as positive control and 0.6 mg/kg body weight was given. 
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555% and 453%, respectively, by treatment of Endo 
III in diabetic group. The treatment of Tfg, Cz and 
glibenclamide for two weeks showed reduced 
oxidative DNA damage in experimental diabetic 
group when compared with untreated group. The 
decrease in the damage index observed was 51%, 
33% and 60% in the liver, 46%, 38% and 58% in the 
brain and 41%, 28% and 53% in the lymphocytes of 
rats receiving treatment of Tfg, Cz and glibenclamide, 
respectively. Treatment of Tfg, Cz and glibenclamide 
also caused significantly marked decrease in the DNA 
damage index in Endo III and Fpg treated slides of the 
liver, brain and lymphocytes of diabetic rats when 
compared with respective control. The decrease in 
DNA damage index observed in Endo treated slides 
was 59%, 23% and 36% in the liver, 39%, 34% and 
47% in the brain and 57%, 48% and 61% in the 
lymphocytes of diabetic rats on Tfg, Cz and 
glibenclamide treatment, respectively, when 
compared with untreated diabetic rats (Table 4). 
Similarly in Fpg treated slides showed 44%, 28% and 
56% decrease in the liver, 32%, 16% and 56% 
decrease in the brain, 51%, 41% and 67% decrease 
DNA damage index observed in the lymphocytes of 
diabetic group when treated with Tfg, Cz and 
glibenclamide for two weeks, respectively, when 
compared with untreated diabetic group (Table 4).  
 
Discussion 
Oxidative stress refers to the imbalance between 
generation and removal of free radicals or the reactive 
oxygen species (ROS) in the biological system. The 
oxidative stress consequently results in damage to all 
the biomolecules including proteins, lipids and DNA 
of the cell. Oxidative stress is the known causative 
factor in several diseases in humans including 
atherosclerosis, heart failure, myocardial infarction, 
schizophrenia, bipolar disorder, fragile X syndrome, 
age related degenerative disorders like parkinson’s 
disease and alzheimer’s disease21,22. Various drugs, 
xenobiotics and environmental pollutants are known 
to cause oxidative stress. Reactive species such as free 
Table 4 — Effect of oral administration of Trigonella foenum graecum seeds and Cinnamomum zeylanicum bark powder for two 
weeks on oxidative DNA damage in the liver, the brain and lymphocytes of control and diabetic rats 
 Groups Buffer Lysis Endo III FPG 
Liver      
 Control 0.22 ± 0.01 0.22 ± 0.02 0.47 ± 0.06 0.88 ± 0.02 
 Diabetic 0.63 ± 0.02** 1.93 ± 0.01*** 2.47 ± 0.12*** 2.50 ± 0.21*** 
 Diabetic + Tfg  
(1740 mg/kg) 
0.38 ± 0.01** 0.95 ± 0.02** 1.02 ± 0.03*** 1.40 ± 0.01** 
 Diabetic + Cz (200 mg/kg) 0.53 ± 0.02* 1.30 ± 0.03** 1.91 ± 0.06** 1.80 ± 0.01** 
 Diabetic + Gli (0.6 mg/kg) 0.32 ± 0.01** 0.77 ± 0.02*** 1.57 ± 0.01** 1.10 ± 0.01*** 
Brain      
 Control 0.13 ± 0.01 0.17 ± 0.01 0.43 ± 0.01 0.32 ± 0.01 
 Diabetic 0.73 ± 0.01** 2.18 ± 0.06*** 2.82 ± 0.02*** 2.60 ± 0.05*** 
 Diabetic + Tfg  
(1740 mg/kg) 
0.51 ± 0.01** 1.18 ± 0.03** 1.73 ± 0.02*** 1.78 ± 0.03** 
 Diabetic + Cz (200 mg/kg) 0.65 ± 0.02* 1.36 ± 0.03** 1.87 ± 0.03** 2.18 ± 0.04** 
 Diabetic + Gli (0.6 mg/kg) 0.42 ± 0.01** 0.92 ± 0.03*** 1.50 ± 0.05*** 1.14 ± 0.31*** 
Lymphocytes      
 Control 0.13 ± 0.02 0.21 ± 0.01 0.59 ± 0.02 0.47 ± 0.01 
 Diabetic 0.79 ± 0.02** 1.88 ± 0.02*** 3.26 ± 0.07*** 2.51 ± 0.03*** 
 Diabetic + Tfg  
(1740 mg/kg) 
0.37 ± 0.02** 1.11 ± 0.04*** 1.40 ± 0.02*** 1.24 ± 0.02** 
 Diabetic + Cz (200 mg/kg) 0.62 ± 0.03* 1.35 ± 0.03** 1.68 ± 0.03** 1.47 ± 0.02** 
 Diabetic + Gli (0.6 mg/kg) 0.30 ± 0.01*** 0.88 ± 0.05*** 1.27 ± 0.02*** 0.82 ± 0.05*** 
Values of DNA damage are expressed as damage index calculated as #0 + #1 + #2 + #3 + #4/ # of cell scored where # is the total number 
of nuclei counted. 
Results are mean ± S.E. of six set of observation. * P < 0.05, ** P < 0.001, *** P < 0.0001 and # P > 0.05 when compared with control. 
Diabetic rats were given aqueous suspension of powdered Trigonella foenum graecum seed and Cinnamomum zeylanicum bark orally at a 
dose of 1740 mg/kg body weight (Tfg) and 200 mg/kg body weight (Cz), with the help of cannula, daily for two week. 
Glibenclamide (Gli) is taken as positive control and 0.6 mg/kg body weight was given. 
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radicals, one-electron oxidants, various chemicals, 
etc., can react with different components of DNA to 
produce a plethora of DNA lesions
23
. These reactive 
species can modify bases
20,23
, induce inter and intra-
strand crosslinks
24
 promote DNA–protein crosslinks23 
and create strand breaks
20
. Several reactive species 
that contain oxygen such as superoxide radical anion 
(O2˙−), hydroxyl radical (OH˙), peroxynitrite 
(ONOO−), hypochlorous acid (HOCl), etc. are 
generated inside the living cells during normal 
metabolic activities
23
. For example, leakage of 
electrons to molecular oxygen (O2) from 
mitochondrial electron transport chains consisting of 
flavoproteins, iron sulphur proteins, ubiquinone and 
cytochromes produces O2˙− and OH˙ radicals are very 
reactive and can damage structures of all components 
of the DNA
25
. Failure to repair damaged lesions of 
DNA is associated with serious consequences 
including genome instability, mitochondrial 
dysfunction, neurodegeneration, aging or cancer
26
. 
Identification of mechanism of damage is important 
and necessary for planning of effective preventive as 
well as therapeutic measures. 
Considerable number of evidences exist showing 
hyperglycemia induced increase in generation of 
ROS, leading to increased oxidative stress in various 
tissues which plays an important role in development 
of diabetic complications
27
.
 
Excessive levels of 
glucose can disrupt the electron transport chain in the 
mitochondria, leading to generation of excess of 
superoxide anions
28,29
. High glucose can also 
stimulate oxidative stress via its auto-oxidation and 
non-enzymatic glycation. Reactive oxygen species 
(ROS) is generated in the process of advanced 
glycation endproducts (AGEs) formation
28
 and 
interaction between AGEs and their receptors, RAGE, 
can also lead to ROS formation
30
. Moreover, 
glycation can inactivate antioxidant enzymes, 
impairing antioxidant defense, as observed with 
glycation of superoxide dismutase
40
. Diabetes caused 
decrease in activity as well as expression of 
antioxidants enzymes namely, glutathione peroxidise 
(GPx), superoxide dismutase (SOD) and catalase 
(CAT) in the tissues of rats
5,11,31
. Hyperglycemia can 
also induce oxidative stress by the polyol pathway. 
There are mainly three potential mechanisms by 
which the polyol pathway contributes to oxidative 
stress. First, under hyperglycemic condition, 
approximately 30% of the glucose is channeled into 
AR-dependent polyol pathway, which depetes 
NADPH and consequently reduces GSH level. 
Second, oxidative stress is produced during the 
conversion of sorbitol into fructose by SDH. In this 
step, the co-factor NAD
+
 is converted to NADH by 
SDH. NADH is a substrate of NADH oxidase leading 
to production of superoxide anions. Third, the polyol 
pathway converts glucose to fructose, and fructose 
can be further metabolized into fructose-3-phosphate 
and 3-deoxyglucosone, which is more potent non-
enzymatic glycation agent than glucose. Thus, the 
flux of glucose through the polyol pathway would 
increase AGEs formation, ultimately leading to ROS 
generation
32
.  
Glutathione (GSH), an important nonenzymatic 
antioxidant, is a vital substance providing antioxidant 
defence and is involved in various other important 
physiological functions like detoxification of 
xenobiotics and also act as substrate and co substrate 
in many enzymatic reactions. GSH plays important 
role in protecting cells against free radical i.e. reactive 
oxygen species (ROS) induced injuries. The cellular 
levels of GSH are very delicately balanced at the 
expense of NADPH. It is reversibly converted to 
GSSG after donating its reducing equivalents in redox 
reactions. Thus the shift of GSH ⇌ GSSG equilibrium 
towards right indicates the disturbance of the redox 
balance in the cells which should be maintained to 
keep the normal cellular physiological state by 
keeping the enzymes and proteins in the active state. 
The present study showed an elevated level of 
superoxide anion and simultaneously decreased TAC 
which is observed in oxidative stress and this 
observation supports the previous studies. Results of 
the present study also showed significantly decreased 
ratios of GSH/GSSG along with NADPH/NADP
+
 and 
NADH/NAD
+
 in the tissues of diabetes rats, 
indicating the induction of oxidative stress because 
the ratios of GSH/GSSG, NAD(P)H/NAD(P)
+
 and 
NADH/NAD
+
 are the indicators of redox status in the 
tissues. Decrease in the GSH level and impairment in 
GSH metabolism have been previously reported in the 
diabetics
33,34
. Decrease level of GSH found due to the 
low level of NADPH and consequent increased 
oxidative stress. Relatively high GSH/GSSG ratios 
are maintained by the enzyme glutathione reductase 
using NADPH
34
. In addition to controlling the activity 
of redox sensitive enzymes, the NAD(P)H/NAD(P)
+
 
ratio can regulate the activity of various transcription 
factors, leading to changes in gene expression. 
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Results of the present study showed that diabetes 
caused extensive DNA damage in rat tissues and 
lymphocytes. DNA oxidation is known to be the most 
common type of DNA damage to human and other 
species in condition of oxidative stress
35
. The elevated 
ROS in diabetes can cause strand breaks and base 
modifications including oxidation of guanine residues 
to 8-OHdG, an oxidized nucleoside of DNA, which is 
the most frequently detected and studied DNA 
lesion
36
. An increased extent of DNA damage in 
T2DM patients compared to controls has also been 
reported in several studies
37
. On the other hand, 
several studies showed the lack of association 
between diabetes and increased DNA damage
37
 while 
some reports are found on a significant positive 
correlation between 8-OHdG, a biomarker of 
oxidative DNA damage
38
, and fasting blood glucose 
and HbA1c
37-40
. Hyperglycemia causes glucose auto-
oxidation, glycation of proteins, activation of polyol 
metabolism and subsequent formation of ROS. The 
present study also revealed increase in damage to 
purines and pyrimidines bases in the tissues of 
diabetic rats. It was observed that damage to purines 
was higher than pyrimidines as Fpg treatment caused 
more increase in DNA damage index in the brain and 
the lymphocytes while in the liver, Endo III treatment 
caused higher damage of pyrimidimes than to purines 
in diabetic group. There are many reports describing 
elevated levels of oxidatively modified DNA lesions, 
in various biological matrices, in a plethora of 
diseases; however, for the majority of these the 
association could merely be coincidental, and more 
detailed studies are required. DNA damage due to 
generation of oxidative stress caused diseases 
including cancer. ROS have influence on almost all 
kinds of cellular activities. Organisms have evolved to 
deal with it, and put the ROS generation into intra- 
and inter-cellular regulatory system that needs to 
coordinate the balanced cell growth that needs to 
involve autophagy and cell death
41
.  
Treatment with Tfg and Cz caused significant 
reduction in the level of superoxide anion with 
simultaneous increase in the TAC as well as ratios of 
GSH/GSSG, NAD(P)H/NAD(P)
+
 and NADH/NAD
+
 
in the diabetic group. The results of our study  
showed that the indices of oxidative stress were 
significantly restored to normal levels on Tfg and  
Cz treatment, while Tfg was more effective than  
Cz. Results of both treatments were also compared 
with standard drug, glibenclamide. The major 
constituents of Tfg are saponin glycoside, 
carbohydrates, and proteins. It is well-established that 
saponins are hypocholesterolemic and antioxidant 
studied in animal species
42
. Therefore, it is possible 
that the presence of saponins in Tfg is responsible for 
the protection against oxidative stress generated 
complications. Similarly the two main components of 
bark of Cz namely cinnamaldehyde and eugenol  
show antioxidant potential. Previous studies have  
also demonstrated that cinnamaldehyde decreased  
the levels of lipid peroxidation products and increased 
the activities of antioxidant enzymes
43 
and eugenol  
(4-allyl-2 methoxyphenol) is natural antioxidant, 
which has phenolic structure, play an important  
role in protecting the tissues against free radical 
induced damage. The antioxidant activity of eugenol 
was evaluated by the extent of protection offered 
against free radical-mediated lipid peroxidation  
using both in vitro and in vivo studies
44
. Hence  
Tfg seed and bark of Cz seem to have therapeutic 
potential against diabetes induced oxidative stress and 
DNA damage which may be related to their free 
radical scavenging properties. Tfg and Cz are reported 
to have antidiabetic and antioxidative properties 
which have been confirmed in the present study
45,46
. 
There are many other plants available with 
antioxidative potential and are being used as remedies 
in diabetes, by reducing oxidative stress and 
consequently their complications such as redox 
imbalanced and DNA damage
47-49
.  
 
Conclusion 
The present study  concluded that Tfg and Cz have 
antihyperglycemic and antioxidative potential against 
diabetes induced redox imbalance. The protective 
effects of Tfg and Cz on DNA damage have also been 
observed in alloxan induced diabetic rats. This 
establishes the efficacy of both the plants which may 
be used as therapeutic agents in the management of 
diabetes. Further studies are required to find out the 
exact mechanism of hypoglycemic action of the Tfg 
seed and Cz bark powder. 
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